ORIGINAL PAPER
Lung cancer incidence trends in Świętokrzyskie Voivodeship in 1999–2013
1
Department of Epidemiology and Cancer Control, Holycross Cancer Centre, Kielce, Poland
2
Faculty of Medical Science, School of Economics, Law, and Medical Science, Kielce, Poland
3
Thoracic Surgery Clinic, Holycross Cancer Centre, Kielce, Poland
4
Department of Education, Jan Kochanowski University, Kielce, Poland
5
Department of Rehabilitation of Hearing and Balance Organs, Institute of Physiotherapy, Faculty of Medicine and Health Science,
Jan Kochanowski University, Kielce, Poland
6
Department of Rehabilitation, Holycross Cancer Centre, Kielce, Poland
7
Rehabilitation Outpatient Clinic, Holycross Cancer Centre, Kielce, Poland
8
Gynaecological Oncology Clinic, Holycross Cancer Centre, Kielce, Poland
9
Clinic of Clinical Oncology, Holycross Cancer Centre, Kielce, Poland
10
Department of Cancer Prevention and Epidemiology, Institute of Public Health, Faculty of Medicine and Health Science,
Jan Kochanowski University, Kielce, Poland
Submission date: 2016-06-15
Acceptance date: 2016-09-26
Publication date: 2017-03-31
Medical Studies 2017;33(1):1-8
KEYWORDS
TOPICS
ABSTRACT
Introduction: Lung cancer is the most common malignant cancer worldwide. In 2013 a total of 21,524 new cases of lung cancer in Poland and 751 (576 in men and 175 in women, respectively) in Świętokrzyskie Voivodeship were reported.
Aim of the research: To assess the dynamics of changes in lung cancer incidence between 1999 and 2013 in the population of inhabitants of Świętokrzyskie Voivodeship by sex.
Material and methods: Eleven thousand four hundred and eighteen new lung cancer cases in Świętokrzyskie Voivodeship in 1999–2013 were analysed. Crude rates (CRs) and age-standardised rates (ASRs) per 105 population were calculated, in general and by sex. The analysis of incidence trends was carried out using joinpoint models.
Results: In 2013 a significant decrease by 22.3% in lung cancer incidence was reported in comparison with the year 1999. A significant decrease by 32.3% among men and non-significant increase by 32.3% in lung cancer incidence among women were reported. The relative risk of lung cancer incidence in men decreased by 44.5% compared to women. The trend in ASRs showed a significant decrease by 2.0% per year. In the male population a significant decreasing trend by 2.9% per year and a significant increasing trend by 2.1% per year among the female population were observed. The lung cancer incidence among men in Świętokrzyskie Voivodeship decreased, with a simultaneous increase in incidence among women in 1999–2013. Sex was the main factor that differentiated the shaping of incidence trends. A significant decreasing incidence trend among men and a significant increasing incidence trend among women were observed.
Conclusions: It is necessary to intensify the primary and secondary prevention of lung cancer in the voivodeship.
Aim of the research: To assess the dynamics of changes in lung cancer incidence between 1999 and 2013 in the population of inhabitants of Świętokrzyskie Voivodeship by sex.
Material and methods: Eleven thousand four hundred and eighteen new lung cancer cases in Świętokrzyskie Voivodeship in 1999–2013 were analysed. Crude rates (CRs) and age-standardised rates (ASRs) per 105 population were calculated, in general and by sex. The analysis of incidence trends was carried out using joinpoint models.
Results: In 2013 a significant decrease by 22.3% in lung cancer incidence was reported in comparison with the year 1999. A significant decrease by 32.3% among men and non-significant increase by 32.3% in lung cancer incidence among women were reported. The relative risk of lung cancer incidence in men decreased by 44.5% compared to women. The trend in ASRs showed a significant decrease by 2.0% per year. In the male population a significant decreasing trend by 2.9% per year and a significant increasing trend by 2.1% per year among the female population were observed. The lung cancer incidence among men in Świętokrzyskie Voivodeship decreased, with a simultaneous increase in incidence among women in 1999–2013. Sex was the main factor that differentiated the shaping of incidence trends. A significant decreasing incidence trend among men and a significant increasing incidence trend among women were observed.
Conclusions: It is necessary to intensify the primary and secondary prevention of lung cancer in the voivodeship.
REFERENCES (27)
1.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: IARC; 2013 [cited 2016 May 10]. Available from: http://globocan.iarc.fr.
2.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012: GLOBOCAN 2012. Int J Cancer 2015; 136: E359-86.
3.
Raporty Krajowego Rejestru Nowotworów [Internet]. [cited 2015 Mar 20]. Available from: http://onkologia.org.pl/raport....
4.
Smok-Kalwat J, Kowalska A, Stępień D, Macek P, Góźdź S. Nowotwory złośliwe w województwie świętokrzyskim w 2013 roku. Świętokrzyskie Centrum Onkologii, Kielce 2015; 69.
5.
Keppel KG, Pearcy JN, Klein RJ. Measuring progress in Healthy People 2010. Healthy People 2010 Stat Notes 2004; 25: 1-16.
6.
Hynes MM, Mueller LM, Li H, Amadeo F. Mortality and its Risk Factors in Connecticut, 1989-1998. Appendix II. Glossary. Hartford CT Conn Dep Public Health 2005; 8.
7.
Panko S, Karpitski A, Shelepen K, Kazarez M, Vakulich D, Boufalik R, Shestiuk A, Zhurbenka G, Ignatiuk A. Epidemiology, diagnostics and long-term overall survival of patients with non-small cell lung cancer in the Brest Region. Stud Med 2013; 29: 203-12.
9.
Olajide O, Field J, Davies M, Marcus M. Lung cancer trend in England for the period of 2002 to 2011 and projections of future burden until 2020. Int J Oncol 2015; 47: 739-46.
10.
Paliogiannis P, Attene F, Cossu A, Budroni M, Cesaraccio R, Tanda F, Trignano M, Palmieri G. Lung cancer epidemiology in North Sardinia, Italy. Multidiscip Respir Med 2013; 8: 45.
11.
Krzakowski M, Jassem J, Dziadziuszko R, Kowalski DM, Olszewski W, Orłowski T, Rzyman W, Smorczewska M. Nowotwory płuca i opłucnej oraz śródpiersia. In: Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych 2013 rok. Krzakowski M, Warzocha K (eds). Vol. I. VM Media Sp z o.o. VM Group sp. k. (Grupa Via Medica), Gdansk 2013; 71-101.
13.
Zatoński W, Górecka D, Opolski G, Pużyński S, Radziwił K, Ziętek M. Konsensus dotyczący rozpoznawania i leczenia zespołu uzależnienia od tytoniu. Gaz Lek 2008; 216: 1-16.
14.
Doll R, Hill AB. The mortality of doctors in relation to their smoking habits. Br Med J 1954; 1: 1451.
15.
Hammond EC, Horn D. Smoking and death rates – report on forty-four months of follow-up of 187,783 men. J Am Med Assoc 1958; 166: 1294-308.
16.
Zatoński WA, Sulkowska U, Didkowska J. Kilka uwag o epidemiologii nowotworów w Polsce. Nowotw J Oncol 2015; 65: 179-96.
17.
Li Y, Sheu CC, Ye Y, de Andrade M, Wang L, Chang SC, Aubry MC, Aakre JA, Allen MS, Chen F, Cunningham JM, Deschamps C, Jiang R, Lin J, Marks RS, Pankratz VS, Su L, Li Y, Sun Z, Tang H, Vasmatzis G, Harris CC, Spitz MR, Jen J, Wang R, Zhang ZF, Christiani DC, Wu X, Yang P. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010; 11: 321-30.
18.
Christiani DC. Lung cancer genetics: a family affair? Clin Cancer Res 2009; 15: 2581-2.
19.
Kępka L. Dylematy radykalnego leczenia onkologicznego chorych na raka płuca w okresie starości. Pneumonol Alergol Pol 2009; 77: 166-72.
20.
Zatoński W, Sulkowska U, Przewoźniak K, Zatoński M. Epidemiologia nowotworów złośliwych w Polsce. In: Zachorowalność i umieralność na nowotwory a sytuacja demograficzna Polski. Potrykowska A, Strzelecki Z, Szymborski J, Witkowski J (eds). Rządowa Rada Ludnościowa, Warsaw 2014; 30-49.
21.
Osińska I, Domagała-Kulawik J. Płukanie oskrzelowo-pęcherzykowe w raku płuca – znaczenie w diagnostyce i ocenie odpowiedzi układu odpornościowego. Postepy Hig Med Dosw (online) 2013; 67: 1119-27.
22.
Kosacka M, Jankowska R. Epidemiologia raka płuca. Pneumonol Alergol Pol 2007; 75: 76-80.
23.
Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Baan R, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group IARC. The carcinogenicity of outdoor air pollution. Lancet Oncol 2013; 14: 1262-3.
25.
National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
26.
Chorostowska-Wynimko J, Demkow U, Górski P, Krenke K, Kurzyna M, Kuś J, Langfort R, Maszkowska-Kopij K, Roszkowski-Śliż K, Skorupa W, Sobczyńska-Tomaszewska A, Szołkowska M, Torbicki A. Postępy w pneumonologii w 2012 roku. Pneumonol Alergol Pol 2013; 81: 162-81.
27.
Orłowski T. Wczesne wykrywanie raka płuca – rola badań przesiewowych. Pneumonol Alergol Pol 2014; 82: 1-2.
Share
RELATED ARTICLE
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
